CYP2D6 phenotype prediction from genotype: which system is the best?
- PMID: 18202689
- DOI: 10.1038/sj.clpt.6100455
CYP2D6 phenotype prediction from genotype: which system is the best?
Abstract
Genotyping of the polymorphic cytochrome P450 (CYP) 2D6 gene is used increasingly in clinical practice. Several psychiatric hospitals already use CYP2D6 testing before treating a patient with antidepressant or antipsychotic drug therapy. In other fields of drug therapy, such as for breast cancer, CYP2D6 status has been reported to be an independent predictor for the outcome with tamoxifen. Thus, a more favorable tamoxifen treatment seems to be feasible through a priori genetic assessment of CYP2D6.
Comment on
-
The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.Clin Pharmacol Ther. 2008 Feb;83(2):234-42. doi: 10.1038/sj.clpt.6100406. Epub 2007 Oct 31. Clin Pharmacol Ther. 2008. PMID: 17971818
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources